| Financial Year |
March 31 2023 |
| Monetary Funds |
568,695,585.12 |
| Held-for-trading Financial Assets |
142,448,922.66 |
| Notes Receivable |
3,601,031.24 |
| Accounts Receivable |
307,132,251.80 |
| Advances to Suppliers |
2,300,437.91 |
| Other Receivables |
10,171,897.32 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
99,430,818.97 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,319,800.72 |
| Total Current Assets |
1,148,681,417.27 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
42,767,517.64 |
| Under-construction Projects |
67,927,406.89 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
74,439,528.59 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
11,697,787.17 |
| Other Non-Current Assets |
14,552,241.05 |
| Sub-Total of Non-Current Assets |
211,705,294.67 |
| Total Assets |
1,360,386,711.94 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
11,834,150.00 |
| Accounts Payable |
90,606,092.68 |
| Accounts Received In Advance |
372,140.06 |
| Employee Compensation Payable |
7,483,427.01 |
| Taxes Payable |
12,786,978.31 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
47,313.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
175,629.31 |
| Other Current Liabilities |
433,704.88 |
| Sub-Total of Current Liabilities |
148,756,038.49 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
843,330.72 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
8,010,500.86 |
| Total Liabilities |
156,766,539.35 |
| Paid-In Capital(Or Share Stock) |
139,280,000.00 |
| Capital Surplus |
541,611,190.61 |
| Surplus Reserve |
49,703,558.65 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
462,988,593.27 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,203,620,172.59 |
| Owner's Equity（Stockholder's Equity） |
1,203,620,172.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,360,386,711.94 |
